Jun 28, 2016
By Pharmaceutical Technology Editors
MilliporeSigma and the International Vaccine Institute in Seoul, South Korea aim to develop more robust, scalable vaccine manufacturing processes.
Jun 28, 2016
Antibodies to dengue may either confer protective immunity to the Zika virus or enhance disease severity in secondary, related infections such as Zika.
Jun 23, 2016
Studying broadly neutralizing antibodies in infants may lead to new pathways in HIV vaccine development.
Jun 16, 2016
A new indication for Emergent BioSolutions’ BioThrax will give the drug market exclusivity through November 2022.
Jun 13, 2016
By Pharmaceutical Technology Editors
FDA approved Vaxchora intended for travelers who are at risk for the disease.
Jun 09, 2016
The inactivated vaccine, manufactured with a GE FlexFactory system, could be associated with fewer adverse reactions than the live vaccine option.
Jun 02, 2016
Pharmaceutical Technology
Experts discuss the key considerations in the development of an autoinjector.
May 15, 2016
Pharmaceutical Technology
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing
May 10, 2016
By Pharmaceutical Technology Editors
Phase I clinical trials of PfSPZ revealed it may protect healthy adults, who have not been exposed to Malaria before, for more than on year.
May 04, 2016
By Pharmaceutical Technology Editors
MilliporeSigma expands its Carlsbad, California-based GMP capacity for viral and gene-therapy products by nearly 90%.
lorem ipsum